{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "Rare Inflammatory Disease Treatment Market to Gain US$ 15,960.8 Mn by 2026 :\u00a0Novartis AG, Abbvie, Abbott Laboratories, Regeneron Pharmaceuticals, Swedish Orphan\u00a0Biovitrum",
    "author_name": "Future Market Insights",
    "author_url": "http:\/\/www.futuremarketinsights.com\/"
}